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Background: Staphyloccocal nuclease domain-containing protein 1 (SND1) is involved in the regulation of gene
expression and RNA protection. While numerous studies have established that SND1 protein expression is modulated
by cellular stresses associated with tumor growth, hypoxia, inflammation, heat-shock and oxidative conditions, little is
known about the factors responsible for SND1 expression. Here, we have approached this question by analyzing the
transcriptional response of human SND1 gene to pharmacological endoplasmic reticulum (ER) stress in liver
cancer cells.
Results: We provide first evidence that SND1 promoter activity is increased in human liver cancer cells upon
exposure to thapsigargin or tunicamycin or by ectopic expression of ATF6, a crucial transcription factor in the
unfolded protein response triggered by ER stress. Deletion analysis of the 5’-flanking region of SND1 promoter
identified maximal activation in fragment (-934, +221), which contains most of the predicted ER stress response
elements in proximal promoter. Quantitative real-time PCR revealed a near 3 fold increase in SND1 mRNA expression by
either of the stress-inducers; whereas SND1 protein was maximally upregulated (3.4-fold) in cells exposed to tunicamycin,
a protein glycosylation inhibitor.
Conclusion: Promoter activity of the cell growth- and RNA-protection associated SND1 gene is up-regulated by ER stress
in human hepatoma cells.
Keywords: SND1 transcriptional activity, Tudor and nuclease domain containing protein 1, Tudor-SN, ER stress response,
ATF6Background
The endoplasmic reticulum (ER) mainly functions in
proper protein synthesis and maturation, and transport
of the correctly folded molecules. When protein folding
or export is perturbed and an excess of misfolded client
proteins accumulate in the ER lumen (ER stress),
eukaryotic cells activate a homeostatic response with
a primarily cytoprotective effect, that is collectively
termed the unfolded protein response (UPR). The UPR
triggers a set of signaling cascades for the control of gene* Correspondence: mariajose.martinez@ehu.es
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unless otherwise stated.transcription and translation programs, which while em-
anating from the ER, requires the nucleus and the Golgi
apparatus for intracellular signal transduction [1]. In
mammals, the principal branches of UPR signaling are
mediated by three ER transmembrane stress sensors:
PERK (double-stranded RNA-activated protein kinase-like
ER kinase), IRE1 (inositol-requiring transmembrane kin-
ase and endonuclease 1) and ATF6 (activating transcrip-
tion factor 6). Under unstressed condition, these sensors
are interacting with the chaperone GRP78 (glucose-
regulated protein 78 or BiP) repressing the signaling
pathways [2,3]. Upon ER stress, GRP78 is sequestered
by unfolded proteins leading to transient and concertedral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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phosphorylation, which mediates general translation at-
tenuation during cellular recovery, PERK-derived ATF4/
ATF3/CHOP pathway, IRE-1-derived XBP1 mRNA spli-
cing and ATF6 activation (recently reviewed in [4,5]). The
three latter pathways induce the expression of distinct but
overlapping sets of genes involved in both general and ER-
specific proteostasis [3,6-9]. Simultaneously, a subset of
cellular mRNAs is translationally silenced by sequestration
into discrete cytoplasmic stress granules until stress miti-
gates or degradation, if ER stress persists [5,10,11].
Staphyloccocal Nuclease Domain containing protein
SND1 (also named Tudor-SN, TSN or p100 coactivator)
is a multidomain protein that appears to have diverse
functions in mammalian cells. Originally described as
a transcriptional coactivator essential for normal cell
growth [12], SND1 serves multiple functions in bio-
logical events spanning from regulation of cell differenti-
ation and proliferation, adipogenesis and biogenesis of
lipid droplets to cellular stress responses [13-18]. SND1
has been demonstrated to act as both a nuclease and a
ligand. The ample distribution of the protein and its cap-
acity for binding RNA and protein molecules explain the
role of SND1 in regulating postranscriptional processes
linked to RNA splicing, editing and silencing [18-21].
Accumulating evidence indicates that SND1 plays an
important role in RNA protection due to its ability to
interact with stress granules protein components and to
degrade highly mutated, hyper-edited regions of double-
stranded RNAs generated during the cellular stress re-
sponse [18,22-24]. SND1 also acts as a microRNA (miR)
binding protein, having been assigned to bind pre-miR-
92a in stress granules and interfere with its maturation
under hypoxic conditions [25]. The interaction of SND1
with mRNAs and miRNAs may be of notable relevance
in cells undergoing a tumor growth-associated stress be-
cause of the potential contribution to angiogenesis regu-
lation. So far, the SND1 overexpression that occurs in
multiple types of cancer cells has been interpreted to
mean parallel activation of the RNA-induced silencing
complex activity and degradation of tumor suppressor
mRNAs [26-29].
In the particular case of liver cancer, SND1 and NF-κB
intersect at several points. SND1 has been shown to
trigger a novel molecular cascade that, mediated by
miR-221 and NF-κB activation, leads to induction of an-
giogenic factors for hepatocellular carcinoma progres-
sion [30]. We demonstrated in human hepatoblastoma
model HepG2 cells, that the evolutionary conserved
SND1 gene promoter is under Sp1 and NF-Y control in
basal conditions and under NF-κB functional binding in
response to TNFα-mediated inflammatory stress [31].
SND1 mRNA overexpression was also found in TNFα-
treated cells [31]. Collectively, these results support theconcept that, in liver carcinoma, there is an intertwined
relationship between SND1 gene expression and tumour
environment inflammation, conditions that are closely
linked to ER stress. Here, we seek to extend the previous
knowledge of gene transcriptional regulation and have an-
alyzed the transcriptional response of human SND1 gene
to pharmacological activation of the UPR in human hepa-
toma cells. Tunicamycin inhibits protein N-glycosylation
[32] and thapsigargin is an inhibitor of the sarco/endoplas-
mic reticulum Ca2+-ATPase pump that disrupts ER cal-
cium homeostasis [33], and both promote accumulation
of misfolded or inadequately processed proteins in the ER
lumen and cause ER stress. We present first experimental
data indicating that promoter activity and expression of
human SND1 gene are activated in cells exposed to thapsi-
gargin or tunicamycin and also following ectopic expres-
sion of the transcription factor ATF6. Moreover, we have
identified the maximal activation in SND/2, a promoter
region of 934 nucleotides upstream the transcription start
site that contains several putative ER stress response ele-
ments (ERSE) for the binding of transcription regulators
ATF6, ATF and XBP1.
Results and discussion
ER stress activates SND1 gene promoter activity
and expression
In light of previous reports showing that SND1 partici-
pates in a range of stress responses including those asso-
ciated with cell growth and inflammation, particularly in
the liver, and that little is known about the factors con-
trolling SND1 gene expression, we investigated the effect
of pharmacologic ER stress on SND1 gene promoter ac-
tivity in human hepatoblastoma cells. We challenged a
human hepatoma cell line, HepG2, with two structurally-
unrelated ER stress-inducing drugs, tunicamycin and
thapsigargin. Both drugs have proven useful for delineat-
ing the molecular grounds of UPR signaling pathways
[32-34]. As Fang established [35], we probed 1 μM thap-
sigargin and 5 μg/ml tunicamycin as the best concen-
trations for inducing ER stress in HepG2 cells while
maintaining cell viability during the 24 h lasting treatment
(data not shown). To investigate the response of SND1
promoter activity to these stress inducers, transcriptional
activity was measured in HepG2 cells transfected with
each of the six 5’ deletion fragments SND/1-SND/6 of the
isolated promoter [GenBank: EF690304] that were gener-
ated and cloned into the Firefly luciferase reporter vector
pGL3-Basic. The fragments comprised the promoter re-
gions -1284, +221; -934, +221; -622, +221; -416, +221;
-274, +221 and -112, +221. Findings revealed that the ac-
tivity provided by each luciferase reporter construct in-
creased upon cell exposure to tunicamycin or thapsigargin
with rises that oscillated between 50% and 90% depending
on the construct (Figure 1A). Maximal activation was
Figure 1 Activation of human SND1 gene promoter activity and expression by endoplasmic reticulum stress. A) HepG2 cells were
transfected with a luciferase reporter gene driven by six different constructs of the human SND1 gene promoter SND/1-6 and used 24 hours
later. Cells were incubated with 5 μg/ml tunicamycin (black) or 1 μM thapsigargin (grey) or the corresponding vehicle (white, control) 2 hours
before transfection. Luciferase activity was calculated using a dual luciferase assay and expressed as fold increase relative to the activity of the
SND/6 fragment in control cells as described in Methods. B) Levels of SND1 mRNA were determined by quantitative real-time PCR in treated and
non-treated HepG2 cells and expressed as relative units, setting to 1.0 the value for control cells. C) SND1 and chaperones GRP78 and GRP94
protein expression was determined by western blotting using β-tubulin as a loading control and expressed as relative units, setting to 1.0 the
value for control cells. Data are presented as mean ± SD from at least three independent experiments. * P < 0.05, ** P < 0.01, *** P < 0.005.
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region -934 upstream the transcription start site.
To examine whether the response of promoter tran-
scriptional activity to ER stressors was paralleled by in-
creases in the expression of SND1 at the level of mRNA
and protein, quantitative real-time PCR and western blot
analyses were performed in untreated and ER stress
inducers-treated cells. Tunicamycin led to a significant
2.7-fold increase in the SND1 mRNA level (Figure 1B)
and 3.4-fold increase in the amount of SND1 protein
(Figure 1C). However, whereas there was a 3.3-fold in-
crease in the SND1 mRNA level (Figure 1B) in thapsi-
gargin treated cells, no change in SND1 protein levels
were observed (Figure 1C). These findings suggest that
each specific form of ER stress promotes differential re-
sponses on SND1 translational programs.The well-established rise in protein levels of the ER
marker chaperones GRP78 and GRP94 was used as a sur-
rogate index of the induction of ER stress. We found that
the protein levels of chaperone GRP78 in tunicamycin- or
thapsigargin-treated cells reached values over 55 and
5 times higher than those measured in control cells
(Figure 1C). However, the rise in GRP94 protein was
higher in thapsigargin- (10 times) than in tunicamycin-
treated cells (5.5 times) (Figure 1C). These findings sug-
gest that the thapsigargin-induced ER calcium loss of
homeostasis [33] and the tunicamycin-induced protein
N-glycosylation blockage [32] result in activation of the
UPR branches of differential intensities, perhaps through
accessory interactions, which might condition the select-
ive induction of gene expression and mRNA translation
attenuation and stress granules formation [9,36]. Despite
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of SND1 gene promoter may be considered one of the
processes of cellular adaptability to stressful conditions in
HepG2 cells. The finding that SND1 protein is overex-
pressed in tunicamycin-treated but not in thapsigargin-
treated cells suggest that the newly transcribed SND1
mRNA may be fully translated when protein glycosylation
is impeded but this protein synthesis is inhibited by
thapsigargin-induced ER stress. The latter is not an unex-
pected finding, in view of that calcium in the ER is re-
quired for the initiation of protein synthesis in almost all
mammalian cell types, and thapsigargin has been dem-
onstrated to sharply and irreversibly suppress amino
acid incorporation within HepG2 [11]. It is conceiv-
able that the primary effect of ER stress is to promote
SND1 gen activity and that SND1 protein outcomes
depend on the nature, intensity and duration of the
stress for fine-tuning the cellular response, with SND1
translation arrest operating when certain ER functional
circumstances associated to serious degrees of stress
are imposed on the cells.
Ectopic expression of ATF6 activates SND1
promoter activity
To further study the stress-induced activation of the
SND1 transcriptional activity, we evaluated the potential
role of the transcription factor ATF6 on SND1 promoter
activity. ATF6 is initially synthesized and retained by
GRP78 in the ER. Upon ER stress, ATF6 is released from
GRP78 and deliver to the Golgi apparatus where it
undergoes proteolytic processing, and the liberated
N-terminal cytosolic fragment ATF6(N) moves then into
the nucleus to activate target genes [5]. For that, plasmid-
mediated ectopic expression of full-length ATF6 was in-
duced in HepG2 cells transfected with each of the six 5’
deletion fragments of the SND1 promoter and luciferase
activity was measured and compared with that shown by
mock transfected cells expressing basal levels of ATF6.
We observed that luciferase activity of the SND/3, SND/4,
SND/5 and SND/6 promoter fragments was either
unaffected or minimally activated by ATF6 expression
(Figure 2A). However, transcriptional activity of the SND/2
fragment increased by 100% in pCGN-ATF6 transfected
HepG2 cells as compared with that measured in mock
transfected cells (Figure 2A). Notably, not only the percent-
age of increase was similar to that caused in the promoter
fragments activity by cell exposure to thapsigargin or tuni-
camycin, but also maximal activation was consistently de-
tected in the SND/2 construct covering the promoter
region (-934, +221) (Figure 2A). Bioinformatic analysis
revealed that region SND/2 contains all the potential
motives for ATF6 and XBP1 binding identified by TESS
[37], Jaspar [38] and MatInspector [39] tools along the
proximal promoter sequence of SND1 gene (GenBank:EF690304), with the exception of ATF at position -949
(Figure 2B). ATF6 can bind to several cis-acting response
elements, namely, ERSE (CCAAT-N9-CCACG), ERSE-II
(ATTGG-N1-CCACG), and UPR element (TGACGT
GG/A) [8]. ATF6 has been identified as the CCACG-
binding protein while the general transcription factor
NF-Y constitutively occupies the CCAAT/ATTGG part of
ERSE and ERSE-II [8]. In previous studies, we demon-
strated that the human SND1 promoter lacks TATA box
and contains GC boxes and two inverted CCAAT boxes
for the functional binding of Sp1 and NF-Y, respect-
ively [31]. We also demonstrated that NF-Y binding
at positions -28 and -61 within the proximal promoter is
crucial for the basal transcription of SND1 gene [31].
These NF-Y binding sites are located quite far from the
predicted stress response elements to be considered as a
part of them according to in silico analysis. However, it
has to be considered that the ERSE motives can be recog-
nized by XBP1 and other transcription factors members
of the CREB/ATF and EBOX/ATF subfamilies and the
basic-region leucine zipper family [8]. Therefore, more
work will be required to identify which of the transcrip-
tion factors, ATF6 or XBP1 or others, and how they act
to regulate the activation of SND1 promoter, and to bet-
ter characterize the branch of the UPR governing the ex-
pression of SND1 gene.
The impact of each UPR branch on liver function in
pathologic states has been discussed by Malhi and col-
leagues, who described the existence of a variety of
crosstalks between ER stress, inflammatory response and
activation of NF-κB in which ATF6 and XBP1 signaling
are involved [40]. We have recently demonstrated that
SND1 promoter transcriptional activity increases in re-
sponse to TNFα-induced inflammatory stress via binding
of NF-κB transcription factor at positions -174 and -116
[31]. Upon such inflammatory stress, a 14-fold induction
in the ER chaperone GRP78 has been measured in
TNFα-treated cells as compared with a negative control
(data not shown) supporting the occurrence of perturba-
tions in the ER functional status that could be modulat-
ing SND1 gene transcription. Nevertheless, since ATF6
does not substantially affect activity in SND/3-6 and
NF-κB mediates its action through -174 and -116 binding
sites, SND1 gene expression activation by these agents
might be well orthogonal.
Conclusions
In conclusion, though the exact function of SND1 in
mammals is yet to be revealed, our findings identify ER
stress as a previously unappreciated up-regulating factor
for SND1 gene expression (see Figure 3 for a graphical
representation of major findings). We encounter for the
first time a direct response of SND1 gene promoter ac-
tivity to pharmacological ER stress and the potential
Figure 2 Ectopic expression of ATF6 transcription factor increases SND1 promoter activity. A) HepG2 cells were co-transfected with the
SND/1-6 constructs of the human SND1 gene promoter and the ATF6 expression vector and used 24 hours later. Luciferase activity was measured
in pCGN-ATF6 transfected cells (grey) and mock transfected cells (white, control) and expressed as fold increase respect to the activity of the SND/6
fragment in control cells. Data are presented as mean ± SD from at least three independent experiments. * P < 0.05, ** P < 0.01. B) Nucleotide sequence
of human SND1 gene proximal promoter [GenBank: EF690304]. The transcription start site (+1) is shown in bold and marked by an arrow. Boxes
indicate putative binding motives for ATF6 or transcription factors from CREB/ATF or EBOX/ATF subfamilies, and XBP1 binding sites are underlined.
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scriptional activation of the human SND1 gene.
Methods
Cells culture and treatment
The HepG2 human hepatocellular carcinoma cells (ATCC,
Manassas, VA, USA) were maintained under an atmos-
phere of 5% CO2 at 37°C in EMEM media (ATCC) supple-
mented with 10% (v/v) foetal bovine serum (ATCC),
2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml
streptomycin (Sigma–Aldrich, St. Louis, MO, USA). Cellswere seeded in 96-well plates (12 × 103 cells per well) for
the reporter assays and in 6-well plates (7 × 105 cells per
well) for mRNA and western blot analysis and were grown
to 60-80% confluence. Cells were incubated for 24-26 h
with 5 μg/ml tunicamycin or 1 μM thapsigargin (Sigma)
and the same volume of the corresponding solvent, metha-
nol or ethanol, was added to the control cells.
Transfections and luciferase reporter assay
Two hours before transfection, cells received tunicamycin,
thapsigargin or the same volume of the corresponding
Figure 3 Scheme illustrating endoplasmic reticulum (ER) stress-mediated activation of SND1 promoter activity. SND1 is an ER stress
target gene. The three families of signal transducers IRE1, PERK and ATF6 sense the protein folding conditions of the ER and transmit that
information, resulting in production of transcription regulators that enter the nucleus to drive transcription of UPR target genes. The ER chaperone
GRP78 is normally bound to these ER stress sensors and keeps them inactive. By blocking protein N-glycosylation and disturbing Ca2+ homeostasis
in the ER, tunicamycin and thapsigargin promote accumulation of misfolded proteins that sequester GRP78, leading to the concerted activation of
the three stress sensors, which work alone or together to activate UPR target genes. Simultaneously, mRNA translation is globally inhibited and a
subset of cellular mRNAs is translationally silenced by sequestration into stress granules. SND1 promoter activity is enhanced by thapsigargin,
tunicamycin or ectopic expression of ATF6.
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9 transfection reagent (Roche Applied Science, Mannheim,
Germany) and received 0.1 μg of the appropriate SND1
promoter reporter vector and 0.1 μg of Renilla luciferase
pRL-TK (Promega, Madison, WI, USA) as internal con-
trol for transfection efficiency. We used six 5’ deletion
fragments SND/1-SND/6 comprising the SND1 pro-
moter regions -1284,+221; -934,+221; -622,+221; -416,
+221; -274,+221 and -112,+221 cloned into the Firefly
luciferase reporter vector pGL3-Basic (Promega) as de-
scribed previously [31]. When indicated, cells were add-
itionally cotransfected with 0.1 μg of the expression
plasmid pCGN-ATF6 (Addgene, Cambridge, MA, USA).
Mock transfections with the corresponding empty
vector were carried out in all cases. After 24 h, cells
were lysated and luciferase activity measured using the
Dual-Luciferase Reporter Assay System (Promega) in
a Synergy™ HT Multi- Detection Microplate Reader
(BioTek Instruments Inc, Winooski, VT, USA). Firefly
luciferase activity from promoter constructs was nor-
malized to Renilla luciferase activity. Assays were per-
formed in triplicate and luciferase values were expressedas relative luminescence units, setting to 1.0 the value for
SND/6 luciferase activity.
RNA extraction and quantitative real-time PCR analysis
Total RNA was extracted from HepG2 cells twenty
four hours after tunicamycin or thapsigargin treatment
using TRIzol reagent (Invitrogene Life Technologies,
Barcelona, Spain) according to the manufacturer’s in-
structions. First strand cDNA was synthesized from
1 μg RNA (NanoDrop ND-1000 spectrophotometer,
NanoDrop Technologies, Wilmington, DE) using the
SuperScript III system (Invitrogen) and PCR analysis
was conducted by the SYBR Green (Applied Biosystem,
Foster City, CA, USA) method. Data are expressed as rela-
tive expression level and are calculated from the Ct values
applying calibration curves and normalized with α-actin,
glyceraldehyde 3-phosphate dehydrogenase and TATA box
binding protein by using GeNorm 3.5 software [41], as
described earlier [42]. The GeneBank accession numbers
and primers sequences are: SND1, NM_014390, for-
ward: GTGATCAGATACCGGCAGGATG, reverse: TCTT
AATAGCTCTGGCCTCTGCAG; α-actin, NM_001101.3,
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CGAGCGCGGCGATATCATCATCC; glyceraldehyde 3-
phosphate dehydrogenase, NM_002046.3, forward: GGT
GAAGCAGGCGTCGGAGG, reverse: GAGGGCAATG




After 24 h of tunicamycin or thapsigargin treatment,
HepG2 cells were washed and lysated. Briefly, proteins
(10 μg) from HepG2 cell lysates were resolved by 9%
SDS-PAGE at 170 V for 1 h and transferred to polyviny-
lidene difluoride membranes by semidry transference
(1 hour at 20 V). SND1 was detected by immunoblot
analysis using antibodies anti-rat SNDp102 that recognize
human SND1 [17] and a peroxidase-coupled goat anti-
rabbit IgG (Sigma). The level of GRP78 and GRP94 was
determined as a marker of ER stress using mouse anti-
KDEL IgG (Merck Millipore, Germany) that recognizes
the peptide sequence SEKDEL of GRP78 and GRP94. For
normalization, β-tubulin was detected by using mouse anti
β-tubulin antibody (Santa Cruz Biotechnology Inc., Dallas,
TX, USA) and secondary horse anti-mouse IgG. Protein
bands were detected using ECL (GE Healthcare Life
Sciences, UK) and quantified by optical densitometry using
QuantityOne software (Bio-Rad Laboratories, Hercules,
CA, USA), as described previously [43]. After nor-
malization, results were expressed as relative units, setting
to 1.0 the value for control cells.
Statistical analysis
The results are shown as the mean ± SD of n independ-
ent experiments. Statistical significance was assessed
using the 2-tailed unpaired Students’ t-test, and is de-
noted * P < 0.05, ** P < 0.01, and *** P < 0.005.
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